Author: Evelyn Lee
Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS-CoV-2 Test
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Oxford Immunotec Announces Agreement with Stop TB Partnership – Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Oxford Immunotec releases the T-SPOT® DiscoveryTM SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Oxford Immunotec Announces New Data on the Utility of T-SPOT®.CMV in Kidney and Stem Cell Transplant
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…
Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel
.media-object__meta > li:nth-child(2){ display:none; } .author-card{ display:none; } .block__sidebar, .pagination{ display:none; } .masthead__content-wrapper{ display:none !important; } .media-object__meta{ display:none !important; }…